News Headline Summary
For Vivus (VVUS): Drug makers looking to tap the obesity market face challenges from the cumbersome prescription process
- Sales of Co.'s Qsymia have already been hurt since the launch in December.
- Co. has asked the FDA to expand distribution to a number of retail pharmacies and expects a decision by April.
- No immediate reaction to the news, last trade at USD 12.96 (-3.35%)
15:13, 02 Jan 2013 -
Subscribe Now to RANsquawk
Click here for a 1 week free trial
RANsquawk provides audio news and commentary for over 15,000
professional traders and brokers worldwide. Services include:
Real-time audio coverage from 0630 to 2130 London time
Teams of analysts covering equities, fixed income, FX and energy markets
Real-time scrolling news service
Daily and weekly pre-market research and calendars
Intra-day market update videos
Daily technical analysis